DAVIDSON MICHAEL H. (Chief Executive Officer) sold 3.0% of their position (11.58K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 1 sale
Filed: 1/9/2026ACC: 0001193125-26-009272
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+433.42K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
0B · 1S
3
Total transactions
445K acquired · 11.58K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−11.58K
Price / share
—
Trade value
—
% of position
3.0%
1/7/2026
390.44K→378.86K
Ordinary Shares
Direct
Shares
+81K
Price / share
—
Trade value
—
% of position
21.4%
1/7/2026
378.86K→459.86K
Total
Net shares
+69.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/7/2026 | S · Sale | −11.58K | — | — | 3.0% | 390.44K | 378.86K |
| Ordinary Shares Direct | 1/7/2026 | A · Award | +81K | — | — | 21.4% | 378.86K | 459.86K |
| Total | +69.42K | $0.00 | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
364K shares
Shares
+364K
Strike price
35.45
Held after
364K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares364K shares | 1/7/2026 | A · Award | +364K | 35.45 | — | 364K |